The Effects of Anger and Joy Expressions on Approach and Avoidance Behaviors in Healthy Volunteers

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Recruiting
CT.gov ID
NCT04899609
Collaborator
(none)
40
1
19
2.1

Study Details

Study Description

Brief Summary

Social interactions are part of our daily lives. Communicating with others is a recurring choice which is based on emotional cues, such as facial expression. Our action must be adapted to the emotional state of our interlocutor, otherwise the investigators will have poor quality interactions An emotional stimulus would cause a conditioned response (innate reaction). Thus, the presence of an angry person would automatically trigger flight behavior. More recently, however, it has been envisioned that this same avoidance behavior could be the result of a goal-directed behvior. In this case, the avoidance behavior would be the result of an evaluation of the consequences of the selected action. These goal-directed behaviors are guided by a mental representation of consequences The project aims to study behavioral choices (approach and avoidance) in response to negative and positive social cues (anger and joy) in 40 healthy volunteers using a computerized neuropsychological task, and to determine wheter these choices are the result of goal-directed behavior.

The study also aims to assess the modulation of behavioral adaptation by the level of impulsivity, lonilness, empathy, and by the capcity to understand others' intenstions.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Behavioral Adaptation to Negative and Positive Social Signals in Healthy Volunteers
    Actual Study Start Date :
    Jun 1, 2021
    Anticipated Primary Completion Date :
    Jun 1, 2022
    Anticipated Study Completion Date :
    Dec 30, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of approach and avoidance behavior in response to positive (joy) and negative (anger) social signals [1 day]

      Calculation of the proportion of avoidance vs. approach choices

    Secondary Outcome Measures

    1. Response time [1 day]

      Computerized measurement of reaction time before clicking to make the avoidance or approach choice

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion criteria:
    • Being between 18 and 65 years old

    • Absence of psychiatric pathology over the entire life

    • Being able to understand the nature, purpose and methodology of the study

    Exclusion criteria:
    • Mental retardation or sever medical co-morbidity

    • Sensory or cognitive disability

    • Pregnant or breastfeeding woman

    • Protection by law (guardianship or curatorship)

    • Deprivation of liberty (by judicial or administrative decision)

    • Exclusion period in relation to another protocol

    • Inability to understand, speak and write French

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University hospital Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Study Director: Emilie Olie, MD PhD, University Hospital, Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04899609
    Other Study ID Numbers:
    • RECHMPL21_0304
    First Posted:
    May 24, 2021
    Last Update Posted:
    Sep 8, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Montpellier

    Study Results

    No Results Posted as of Sep 8, 2021